CASEY CLARK: Open Payments
NPI 1518308923 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 16 payments from 9 companies in 2025. Trend: 2023 $262 · 2024 $276 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $86 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| E.R. Squibb & Sons, L.L.C. | 1 | $39 |
| ABBVIE INC. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Boston Scientific Corporation | 1 | $22 |
| ViiV Healthcare Company | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
Products named: Wegovy, Ozempic, COBENFY, VRAYLAR, AIRSUPRA, REXULTI, WaveWriter Alpha Prime 16, APRETUDE.
Industry payments across NC — which companies pay providers there.
